A recent literature review compiles a panel’s consensus and opinion on the main pediatric impetigo controversies.
A recent study in the Journal of Chemotherapy examined the main controversies pertaining to pediatric impetigo.1 After a preliminary virtual meeting in July 2020, an Italian panel of multispecialty clinicians (pediatrics, infectious disease, dermatology, pharmacology, and microbiology) identified the main controversies and collected the pros and con arguments on each. The paper aimed to reach a consensus to help improve the management of pediatric impetigo and reduce inappropriate antibiotic use and resistance.
To find the controversies, a preliminary literature search was conducted using PubMed, MedLine, and Cochrane Library. Only literature published in English was included in the search.
Each controversy was discussed from a multidisciplinary perspective until reaching a consensus during the final meeting held November 2020. In order to reach consensus, total agreement among participants was needed. methicillin-resistant Staphylococcus aureus
The main controversies identified were:
1. Galli L, Novelli A, Ruggiero G, Stefani S, Fortina AB. Pediatric impetigo: an expert panel opinion about its main controversies. Journal of Chemotherapy. Published online August 18, 2021:1-7.